Large scale genotype‐ and phenotype‐driven machine learning in Von Hippel‐Lindau disease
暂无分享,去创建一个
Arun K. Ramani | Lana M. Sheta | Kaitlin A. Clark | O. Griffith | M. Griffith | A. Ramani | Kilannin Krysiak | Arpad M. Danos | Lynzey Kujan | R. Giles | L. Erdman | E. Maher | Yasser Salama | Raymond H. Kim | Yizhuo Gao | K. Farncombe | L. McCoy | Samantha Macpherson | A. Goldenberg | Andreea Chiorean | Jason Saliba | P. Jani | Sean Delong | Clarissa Chan | Veronica Andric | S. Ansar | J. Saliba
[1] Jingcheng Zhou,et al. The Genotype-Phenotype Association of Von Hipple Lindau Disease Based on Mutation Locations: A Retrospective Study of 577 Cases in a Chinese Population , 2020, Frontiers in Genetics.
[2] Ryan L. Collins,et al. The mutational constraint spectrum quantified from variation in 141,456 humans , 2020, Nature.
[3] Shengjie Liu,et al. Frequent Mutations of VHL Gene and the Clinical Phenotypes in the Largest Chinese Cohort With Von Hippel–Lindau Disease , 2019, Front. Genet..
[4] A. Latronico,et al. New Insights Into Pheochromocytoma Surveillance of Young Patients With VHL Missense Mutations , 2019, Journal of the Endocrine Society.
[5] Tudor Groza,et al. Expansion of the Human Phenotype Ontology (HPO) knowledge base and resources , 2018, Nucleic Acids Res..
[6] Shraddha Pai,et al. Patient Similarity Networks for Precision Medicine. , 2018, Journal of molecular biology.
[7] H. Amthauer,et al. Preventive medicine of von Hippel-Lindau disease-associated pancreatic neuroendocrine tumors. , 2018, Endocrine-related cancer.
[8] W. Linehan,et al. In silico VHL Gene Mutation Analysis and Prognosis of Pancreatic Neuroendocrine Tumors in von Hippel–Lindau Disease , 2018, The Journal of clinical endocrinology and metabolism.
[9] S. Peng,et al. Genotype and phenotype correlation in Von Hippel-Lindau disease based on the alteration of HIF-α binding site in VHL protein , 2018 .
[10] D. Malkin,et al. Evidence for genetic anticipation in vonHippel-Lindau syndrome , 2018, Journal of Medical Genetics.
[11] Raymond Dalgleish,et al. VariantValidator: Accurate validation, mapping, and formatting of sequence variation descriptions , 2017, Human mutation.
[12] S. Libutti,et al. Association of VHL Genotype With Pancreatic Neuroendocrine Tumor Phenotype in Patients With von Hippel–Lindau Disease , 2018, JAMA oncology.
[13] Lily Hoffman-Andrews. The known unknown: the challenges of genetic variants of uncertain significance in clinical practice , 2017, Journal of law and the biosciences.
[14] Lana X. Garmire,et al. More Is Better: Recent Progress in Multi-Omics Data Integration Methods , 2017, Front. Genet..
[15] Steven J. M. Jones,et al. CIViC is a community knowledgebase for expert crowdsourcing the clinical interpretation of variants in cancer , 2017, Nature Genetics.
[16] J. Kuratsu,et al. Development of Database and Genomic Medicine for von Hippel-Lindau Disease in Japan , 2017, Neurologia medico-chirurgica.
[17] L. Krogh,et al. Management of Gene Variants of Unknown Significance: Analysis Method and Risk Assessment of the VHL Mutation p.P81S (c.241C>T) , 2016, Current genomics.
[18] W. Chung,et al. Von Hippel-Lindau Disease: Genetics and Role of Genetic Counseling in a Multiple Neoplasia Syndrome. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] E. Budtz-Jørgensen,et al. Survival and causes of death in patients with von Hippel-Lindau disease , 2016, Journal of Medical Genetics.
[20] Silvio C. E. Tosatto,et al. VHLdb: A database of von Hippel-Lindau protein interactors and mutations , 2016, Scientific Reports.
[21] Seung Jun Lee,et al. Genotype-phenotype analysis of von Hippel-Lindau syndrome in Korean families: HIF-α binding site missense mutations elevate age-specific risk for CNS hemangioblastoma , 2016, BMC Medical Genetics.
[22] Raymond Dalgleish,et al. HGVS Recommendations for the Description of Sequence Variants: 2016 Update , 2016, Human mutation.
[23] Matthew S. Lebo,et al. Performance of ACMG-AMP Variant-Interpretation Guidelines among Nine Laboratories in the Clinical Sequencing Exploratory Research Consortium. , 2016, American journal of human genetics.
[24] Heidi L Rehm,et al. ClinGen--the Clinical Genome Resource. , 2015, The New England journal of medicine.
[25] Bale,et al. Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.
[26] M. Ritchie,et al. Methods of integrating data to uncover genotype–phenotype interactions , 2015, Nature Reviews Genetics.
[27] Richard A Armstrong,et al. When to use the Bonferroni correction , 2014, Ophthalmic & physiological optics : the journal of the British College of Ophthalmic Opticians.
[28] Benjamin M. Good,et al. Organizing knowledge to enable personalization of medicine in cancer , 2014, Genome Biology.
[29] Zhuowen Tu,et al. Similarity network fusion for aggregating data types on a genomic scale , 2014, Nature Methods.
[30] E. D. de Vries,et al. Calculating optimal surveillance for detection of von Hippel-Lindau-related manifestations. , 2013, Endocrine-related cancer.
[31] K. Tamura,et al. Pancreatic involvement in Japanese patients with von Hippel-Lindau disease: results of a nationwide survey , 2014, Journal of Gastroenterology.
[32] William R Pearson,et al. Selecting the Right Similarity‐Scoring Matrix , 2013, Current protocols in bioinformatics.
[33] M. Kosteljanetz,et al. Von Hippel-Lindau disease (vHL): National clinical guideline for diagnosis and surveillance in Denmark , 2013 .
[34] L. Sunde,et al. National clinical guideline for diagnosis and surveillance in Denmark 3 rd Edition , 2013 .
[35] S. Richard,et al. von Hippel–Lindau disease: A clinical and scientific review , 2011, European Journal of Human Genetics.
[36] S. Uhrig,et al. Pheochromocytoma in a 2.75‐year‐old‐girl with a germline von Hippel–Lindau mutation Q164R , 2010, American journal of medical genetics. Part A.
[37] A. V. D. van den Ouweland,et al. Genetic analysis of von Hippel‐Lindau disease , 2010, Human mutation.
[38] E. Budtz-Jørgensen,et al. Surveillance in von Hippel‐Lindau disease (vHL) , 2010, Clinical genetics.
[39] S. Tavtigian,et al. In silico analysis of missense substitutions using sequence‐alignment based methods , 2008, Human mutation.
[40] Peter L Choyke,et al. Clinical, genetic and radiographic analysis of 108 patients with von Hippel-Lindau disease (VHL) manifested by pancreatic neuroendocrine neoplasms (PNETs). , 2007, Surgery.
[41] Ulrike von Luxburg,et al. A tutorial on spectral clustering , 2007, Stat. Comput..
[42] E. Maher,et al. Genotype–phenotype correlations in von Hippel‐Lindau disease , 2004, Human mutation.
[43] Kentaro Takahashi,et al. Von Hippel-Lindau Disease , 2024 .
[44] C. Sander,et al. The amino-acid mutational spectrum of human genetic disease , 2003, Genome Biology.
[45] Yigong Shi. Faculty Opinions recommendation of Structure of an HIF-1alpha -pVHL complex: hydroxyproline recognition in signaling. , 2002 .
[46] D. Nickerson,et al. Variation is the spice of life , 2001, Nature Genetics.
[47] Michael I. Jordan,et al. On Spectral Clustering: Analysis and an algorithm , 2001, NIPS.
[48] G. Mortier,et al. Genotype-phenotype correlations in families with deletions in the von Hippel-Lindau (VHL) gene , 2000, Human Genetics.
[49] C Béroud,et al. UMD (Universal Mutation Database): A generic software to build and analyze locus‐specific databases , 2000, Human mutation.
[50] C. Wykoff,et al. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis , 1999, Nature.
[51] W. Kaelin,et al. Structure of the VHL-ElonginC-ElonginB complex: implications for VHL tumor suppressor function. , 1999, Science.
[52] S. Richard,et al. Somatic inactivation of the VHL gene in Von Hippel-Lindau disease tumors. , 1997, American journal of human genetics.
[53] F. Chen,et al. Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. , 1996, Journal of medical genetics.
[54] P. Schofield,et al. Expression of the von Hippel-Lindau disease tumour suppressor gene during human embryogenesis. , 1996, Human molecular genetics.
[55] B. Zbar,et al. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. , 1995, Human molecular genetics.
[56] P. Choyke,et al. von Hippel-Lindau disease: genetic, clinical, and imaging features. , 1995, Radiology.
[57] M. Ferguson-Smith,et al. Clinical features and natural history of von Hippel-Lindau disease. , 1990, The Quarterly journal of medicine.
[58] A. Knudson. Mutation and cancer: statistical study of retinoblastoma. , 1971, Proceedings of the National Academy of Sciences of the United States of America.
[59] P. Jaccard. THE DISTRIBUTION OF THE FLORA IN THE ALPINE ZONE.1 , 1912 .